About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
BJU International
›
Top Articles
BJU International
Urology
5.6
(top 2%)
Impact Factor
6.3
(top 2%)
extended IF
150
(top 2%)
H-Index
4.5K
authors
12.5K
papers
324.7K
citations
8K
citing journals
63.9K
citing authors
Most Cited Articles of BJU International
Title
Year
Citations
How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study
2001
1.2K
The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences
1999
771
Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction
2011
596
The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study
2008
580
The Bristol Female Lower Urinary Tract Symptoms questionnaire: development and psychometric testing
1996
502
The prevalence of urinary incontinence in women in four European countries
2004
488
Robotically-assisted laparoscopic radical prostatectomy
2001
473
The prevalence of lower urinary tract symptoms (LUTS) in the USA, the UK and Sweden: results from the Epidemiology of LUTS (EpiLUTS) study
2009
467
Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial
1998
462
Nerve-sparing robot-assisted radical cystoprostatectomy and urinary diversion
2003
461
A prospective comparison of radical retropubic and robot-assisted prostatectomy: experience in one institution
2003
449
Prognostic Gleason grade grouping: data based on the modified Gleason scoring system
2013
427
Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial
2003
406
The efficacy and safety of degarelix: a 12-month, comparative, randomized, open-label, parallel-group phase III study in patients with prostate cancer
2008
402
The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus
2004
387
Bladder outlet obstruction index, bladder contractility index and bladder voiding efficiency: three simple indices to define bladder voiding function
1999
374
Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome
2005
350
Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group
2012
330
Tolterodine, a new antimuscarinic agent: as effective but better tolerated than oxybutynin in patients with an overactive bladder
1998
330
Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis
2000
325
Randomized, double-blind placebo- and tolterodine-controlled trial of the once-daily antimuscarinic agent solifenacin in patients with symptomatic overactive bladder
2004
314
Anatomical studies of the neurovascular bundle and cavernosal nerves
2004
307
Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging-targeted and systematic biopsy for significant prostate cancer detection
2011
305
Scarless single port transumbilical nephrectomy and pyeloplasty: first clinical report
2008
303
Increased nerve growth factor levels in the urinary bladder of women with idiopathic sensory urgency and interstitial cystitis
1997
300
previous
2002
2003
2004
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.